Saving the jewel in the crown of ‘UKplc’: Brexit’s impact on pharma
Pharma must embrace the opportunity to shape the UK’s political agenda in its favour.
Pharma must embrace the opportunity to shape the UK’s political agenda in its favour.
What can the AAR do for the UK pharma industry, the health service and patients?